Array Biopharma melanoma drug succeeds in late-stage study

(Reuters) - Drug developer Array BioPharma Inc said its experimental drug helped patients with a form of melanoma live longer without their cancer progressing, in a late-stage study.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro